Ataraxis AI
Delaware, Delaware, United States
Ataraxis AI is a healthcare startup focused on transforming precision medicine, specifically in cancer care, through innovative AI-native diagnostic technologies. The company has launched Ataraxis Breast, a pioneering AI-driven prognostic and predictive test for breast cancer that harnesses advanced multi-modal data analysis to assess tumor characteristics and predict treatment outcomes. Their proprietary AI foundation models, such as Kestrel, analyze vast amounts of pathology slide images to uncover crucial insights about tumor morphology and patient prognosis. With a commitment to improving treatment selection and patient outcomes, Ataraxis AI collaborates with leading cancer centers and utilizes cutting-edge techniques to deliver fast, accurate diagnostic results, enabling better patient management and care strategies.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2022
- Website
- www.ataraxis.ai/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Ataraxis AI?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now